Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

China SXT Pharmaceuticals (SXTC) Other Gross PP&E Adjustments (2018 - 2025)

China SXT Pharmaceuticals (SXTC) has 8 years of Other Gross PP&E Adjustments data on record, last reported at $2.2 million in Q1 2025.

  • For Q1 2025, Other Gross PP&E Adjustments fell 1.12% year-over-year to $2.2 million; the TTM value through Mar 2025 reached $2.2 million, down 1.12%, while the annual FY2025 figure was $2.2 million, 1.12% down from the prior year.
  • Other Gross PP&E Adjustments reached $2.2 million in Q1 2025 per SXTC's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $2.7 million in Q1 2022 and bottomed at $1.9 million in Q1 2023.
  • Average Other Gross PP&E Adjustments over 5 years is $2.3 million, with a median of $2.3 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: decreased 29.17% in 2023, then grew 18.65% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.5 million in 2021, then rose by 5.96% to $2.7 million in 2022, then fell by 29.17% to $1.9 million in 2023, then increased by 18.65% to $2.3 million in 2024, then fell by 1.12% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $2.2 million in Q1 2025, $2.3 million in Q1 2024, and $1.9 million in Q1 2023.